Российский журнал гастроэнтерологии, гепатологии, колопроктологии (Aug 2018)

Efficacy and safety of glycyrrhizic acid combined to essential phospholipids (Phosphogliv) at non-alcoholic fatty liver disease: results of multicenter double blind randomized placebo-controlled post-registration clinical study (IV phase) «Gepard» (PHG-M2/P02-12)

  • V. T. Ivashkin,
  • I. G. Bakulin,
  • P. O. Bogomolov,
  • M. V. Matsiyevich,
  • N. I. Geyvandova,
  • P. V. Koroy,
  • S. V. Nedogoda,
  • O. A. Sablin,
  • L. G. Lenskaya,
  • Ye. V. Beloborodova,
  • A. A. Bagretsova,
  • R. A. Abdulkhakov,
  • M. F. Osipenko,
  • I. V. Osipova,
  • D. A. Pocheptsov,
  • Ye. V. Chumachek,
  • O. M. Khromtsova,
  • Ye. V. Kuzmicheva

DOI
https://doi.org/10.22416/1382-4376-2017-27-2-34-43
Journal volume & issue
Vol. 27, no. 2
pp. 34 – 43

Abstract

Read online

No abstracts available.

Keywords